BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14976459)

  • 1. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
    Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
    Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
    Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
    Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
    Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
    Chan NN; Fuller JH; Rubens M; Colhoun HM
    Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
    Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
    De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
    Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy].
    Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Cheng YS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):729-31. PubMed ID: 15958323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
    Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
    Antoniades C; Tousoulis D; Tountas C; Tentolouris C; Toutouza M; Vasiliadou C; Tsioufis C; Toutouzas P; Stefanadis C
    Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor and its propeptide in children with diabetes. Relation between endothelial dysfunction and microalbuminuria.
    Verrotti A; Greco R; Basciani F; Morgese G; Chiarelli F
    Pediatr Res; 2003 Mar; 53(3):382-6. PubMed ID: 12595584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
    Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
    Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
    Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
    Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure.
    Fioretto P; Stehouwer CD; Mauer M; Chiesura-Corona M; Brocco E; Carraro A; Bortoloso E; van Hinsbergh VW; Crepaldi G; Nosadini R
    Diabetologia; 1998 Feb; 41(2):233-6. PubMed ID: 9498659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
    Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
    Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
    Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
    Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker.
    Tarkun I; Cetinarslan B; Cantürk Z; Tarkun P; Agaçdiken A; Komsuoglu B
    J Diabetes Complications; 2004; 18(3):165-8. PubMed ID: 15145328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.